Lv3
396 积分 2025-08-27 加入
Risk factors for the formation and rupture of intracranial saccular aneurysms in Shimane, Japan
4天前
已完结
Effectiveness and safety of apixaban and warfarin in patients with new- onset atrial fibrillation after advanced chronic kidney disease or end-stage kidney disease
9天前
已完结
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease
9天前
已完结
Safety and efficacy of apixaban versus low-molecular weight heparin or vitamin-K antagonists for venous thromboembolism treatment in patients with severe renal failure: A systematic review and meta-analysis
9天前
已完结
Oral Anticoagulation in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. PracticeUpdate
9天前
已关闭
In advanced CKD with high CV risk, low-dose rivaroxaban vs. placebo did not reduce CV events and increased major bleeding
9天前
已完结
ROCKET AF Steering Committee and Investigators. Intracranial hemorrhage among patients with atrial fibrillation anti- coagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation
9天前
已关闭
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
20天前
已完结
Exploring the Molecular Pathways of Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease Using Proteomic Analysis
1个月前
已完结
基于HPA特征从益气温阳理论探讨雷火灸干预免疫检查点抑制剂相关癌因性疲乏的作用机制
皖公网安备34019202002308
